Empresa Arca Biopharma Inc Nasdaq
Acciones
US00211Y4070
Biotecnología e investigación médica
Resumen de negocios
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Thomas Keuer
CEO | Chief Executive Officer | 65 | 01/10/06 |
C. Dekker
DFI | Director of Finance/CFO | 60 | 10/05/21 |
Sharon Perry
LAW | General Counsel | - | 01/01/08 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Anders Hove
BRD | Director/Board Member | 58 | 16/02/17 |
Robert Conway
CHM | Chairman | 70 | 03/09/13 |
Linda Grais
BRD | Director/Board Member | 68 | 01/05/07 |
Jacob Ma-Weaver
BRD | Director/Board Member | 37 | 15/06/22 |
James Flynn
BRD | Director/Board Member | 43 | 15/12/22 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 14 507 143 | 14 320 024 ( 98,71 %) | 0 | 98,71 % |
Información de la empresa
ARCA biopharma, Inc.
10170 Church Ranch Way Suite 100
80021, Westminster
+720 940 2200
http://www.arcabio.comSector
Varia. 1 de ene. | Capi. | |
---|---|---|
+5,33 % | 111 mil M | |
+12,11 % | 106 mil M | |
-12,56 % | 22,24 mil M | |
-3,46 % | 21,25 mil M | |
-5,57 % | 18,97 mil M | |
-35,21 % | 18,52 mil M | |
-10,86 % | 16,81 mil M | |
+37,57 % | 12,54 mil M | |
-26,24 % | 8089,74 M |